Carl Zeiss Meditec slumps after currency effects, tariffs hurt Q3 earnings

Carl Zeiss Meditec AG

07/08/2025 09:42

** Carl Zeiss Meditec AFXG.DE shares fall 12.7% to their lowest level in nearly eight years after the German medical technology firm misses Q3 profit expectations, flags negative currency effects

** "EBITA was a 4.8% miss and EPS a 22.5% miss," analysts at J.P. Morgan say, adding that unchanged 2025 guidance "is now caveated with FX headwind risk"

** The brokerage notes the large EBITA miss came in Microsurgery, due to lower neurosurgical volumes and negative tariff and FX impact

** CEO Maximilian Foerst says in a statement the company had to grapple with negative currency impacts and the introduction of US trade tariffs in the quarter

** JPM analysts say they still see risks to the FY outlook, citing "continued softness in China, weaker equipment growth, tariffs" on top of the currency effects

** Carl Zeiss' shares are at the bottom of the European STOXX 600 .STOXX index

 (Reporting by Maria Rugamer)

 ((Maria.Rugamer@thomsonreuters.com))